Hopp til innhold
Close

Get alerts of updates about «CeFH lunch seminar: NMR Metabolomics in large-scale cohorts: Molecular insights and translational outlook»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • CeFH lunch seminar: NMR Metabolomics in large-scale cohorts: Molecular insights and translational outlook

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Event

CeFH lunch seminar: NMR Metabolomics in large-scale cohorts: Molecular insights and translational outlook

Presentation by Peter Würtz, Nightingale Health

Presentation by Peter Würtz, Nightingale Health


1. Nov | 2019

11:00-12:00
Marcus Thranes gate 2, meeting room 201, 2nd floor

Peter Würtz and Nikolaos Tertipis from Nightingale Health are visiting the Centre for Fertility and Health.

Peter Würtz will be talking about "NMR Metabolomics in large-scale cohorts: Molecular insights and translational outlook". The presentation will focus on scientific applications of the metabolomics platform to a wide range of chronic diseases, including the onset of diabetes and related complications, cardiovascular diseases, certain cancers as well as frailty and ageing. It will also touch upon combining metabolomics data and genetics to enhance drug development. As an example, it will then go on to elaborate on how the translation of such study results to individual patient use will be outlined in terms of enhanced disease prediction and health tracking, as already adopted by private healthcare in Scandinavia. To conclude, the presentation will demonstrate how the cost-effective measurement of numerous blood biomarkers in one go opens up a whole new spectrum of applications in large biobanks with rapid integration to preventive care.